Latest Insider Transactions at Syneos Health, Inc. (SYNH)
This section provides a real-time view of insider transactions for Syneos Health, Inc. (SYNH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Syneos Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Syneos Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2021
|
Thomas H. Lee Advisors, LLC |
SELL
Open market or private sale
|
Direct |
2,358
-97.84%
|
$190,998
$81.2 P/Share
|
|
Jun 07
2021
|
Thomas H. Lee Advisors, LLC |
SELL
Open market or private sale
|
Indirect |
10,086,016
-96.24%
|
$816,967,296
$81.2 P/Share
|
|
Jun 07
2021
|
Advent International Corp |
SELL
Open market or private sale
|
Indirect |
37,844,934
-97.83%
|
$3,065,439,654
$81.2 P/Share
|
|
Jun 07
2021
|
Tom Allen |
SELL
Open market or private sale
|
Indirect |
6,307,489
-97.83%
|
$510,906,609
$81.2 P/Share
|
|
Jun 07
2021
|
John L. Maldonado |
SELL
Open market or private sale
|
Indirect |
6,307,489
-97.83%
|
$510,906,609
$81.2 P/Share
|
|
Jun 01
2021
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,889
-2.38%
|
$430,232
$88.2 P/Share
|
|
Jun 01
2021
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,889
+2.33%
|
$205,338
$42.88 P/Share
|
|
May 14
2021
|
Advent International Corp |
SELL
Open market or private sale
|
Indirect |
2,693,652
-6.64%
|
$218,185,812
$81.04 P/Share
|
|
May 14
2021
|
Tom Allen |
SELL
Open market or private sale
|
Indirect |
448,942
-6.64%
|
$36,364,302
$81.04 P/Share
|
|
May 14
2021
|
John L. Maldonado |
SELL
Open market or private sale
|
Indirect |
448,942
-6.64%
|
$36,364,302
$81.04 P/Share
|
|
May 13
2021
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Bona fide gift
|
Direct |
500
-2.02%
|
-
|
|
May 12
2021
|
Thomas H. Lee Advisors, LLC |
SELL
Open market or private sale
|
Direct |
178
-7.04%
|
$14,418
$81.04 P/Share
|
|
May 12
2021
|
Thomas H. Lee Advisors, LLC |
SELL
Open market or private sale
|
Indirect |
759,578
-6.8%
|
$61,525,818
$81.04 P/Share
|
|
May 12
2021
|
Bernadette Connaughton Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,364
+25.04%
|
-
|
|
May 12
2021
|
John M. Dineen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,364
+10.67%
|
-
|
|
May 12
2021
|
Linda S Harty Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,364
+20.29%
|
-
|
|
May 12
2021
|
William E Klitgaard Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,364
+12.47%
|
-
|
|
May 12
2021
|
Kenneth F Meyers Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,364
+12.02%
|
-
|
|
May 12
2021
|
Matthew E. Monaghan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,364
+12.02%
|
-
|
|
May 12
2021
|
Thomas H. Lee Advisors, LLC |
BUY
Grant, award, or other acquisition
|
Direct |
9,456
+15.0%
|
-
|
|
May 06
2021
|
Thomas H. Lee Advisors, LLC |
SELL
Open market or private sale
|
Direct |
1,588
-19.84%
|
$128,628
$81.04 P/Share
|
|
May 06
2021
|
Thomas H. Lee Advisors, LLC |
SELL
Open market or private sale
|
Indirect |
6,781,776
-19.2%
|
$549,323,856
$81.04 P/Share
|
|
May 06
2021
|
Advent International Corp |
SELL
Open market or private sale
|
Indirect |
24,049,908
-19.17%
|
$1,948,042,548
$81.04 P/Share
|
|
May 06
2021
|
John L. Maldonado |
SELL
Open market or private sale
|
Indirect |
4,008,318
-19.17%
|
$324,673,758
$81.04 P/Share
|
|
May 06
2021
|
Tom Allen |
SELL
Open market or private sale
|
Indirect |
4,008,318
-19.17%
|
$324,673,758
$81.04 P/Share
|
|
Apr 15
2021
|
Michelle Keefe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,736
-5.87%
|
$224,352
$82.0 P/Share
|
|
Apr 15
2021
|
Jason M. Meggs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-9.0%
|
$504,000
$84.0 P/Share
|
|
Apr 09
2021
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,039
-6.54%
|
$1,123,120
$80.0 P/Share
|
|
Apr 01
2021
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
17,398
-2.54%
|
$1,339,646
$77.21 P/Share
|
|
Apr 01
2021
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,398
+6.98%
|
$695,920
$40.12 P/Share
|
|
Mar 31
2021
|
Michelle Keefe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,000
-4.11%
|
$156,000
$78.0 P/Share
|
|
Mar 29
2021
|
Linda S Harty Director |
SELL
Open market or private sale
|
Direct |
7,310
-51.35%
|
$555,560
$76.49 P/Share
|
|
Mar 29
2021
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Open market or private sale
|
Direct |
4,000
-13.93%
|
$308,000
$77.0 P/Share
|
|
Mar 15
2021
|
Donna Hildebrand Kralowetz EVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,348
+15.57%
|
-
|
|
Mar 03
2021
|
Thomas H. Lee Advisors, LLC |
SELL
Open market or private sale
|
Direct |
1,870
-16.02%
|
$138,380
$74.17 P/Share
|
|
Mar 03
2021
|
Thomas H. Lee Advisors, LLC |
SELL
Open market or private sale
|
Indirect |
7,990,038
-15.52%
|
$591,262,812
$74.17 P/Share
|
|
Mar 03
2021
|
Advent International Corp |
SELL
Open market or private sale
|
Indirect |
27,924,276
-15.5%
|
$2,066,396,424
$74.17 P/Share
|
|
Mar 03
2021
|
Tom Allen |
SELL
Open market or private sale
|
Indirect |
4,654,046
-15.5%
|
$344,399,404
$74.17 P/Share
|
|
Mar 03
2021
|
John L. Maldonado |
SELL
Open market or private sale
|
Indirect |
4,654,046
-15.5%
|
$344,399,404
$74.17 P/Share
|
|
Mar 03
2021
|
Donna Hildebrand Kralowetz EVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
248
-4.0%
|
$18,352
$74.64 P/Share
|
|
Mar 02
2021
|
Jonathan Olefson General Counsel & Corp Secty |
BUY
Grant, award, or other acquisition
|
Direct |
1,833
+3.12%
|
-
|
|
Mar 02
2021
|
Paul Colvin Pres., Clinical Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
2,677
+4.22%
|
-
|
|
Mar 02
2021
|
Michelle Keefe Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,398
-6.53%
|
$254,850
$75.5 P/Share
|
|
Mar 02
2021
|
Michelle Keefe Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,755
+2.61%
|
-
|
|
Mar 02
2021
|
Jason M. Meggs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,278
-3.3%
|
$170,850
$75.5 P/Share
|
|
Mar 02
2021
|
Jason M. Meggs Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,258
+2.33%
|
-
|
|
Mar 02
2021
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
31,814
-7.2%
|
$2,386,050
$75.5 P/Share
|
|
Mar 02
2021
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,429
+13.59%
|
-
|
|
Mar 02
2021
|
Alistair Macdonald Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,301
+2.88%
|
-
|
|
Feb 16
2021
|
Michelle Keefe Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,880
-5.53%
|
$224,640
$78.59 P/Share
|